|
Pharmacology
Citations 141-150 of 165 total displayed.
|
Past content
(since Dec 2002):
|
- CLINICAL
Discrepancies between the EULAR response criteria and the NICE guidelines for continuation of anti-TNF therapy in RA: a cause for concern?
- S. Jerram, S. Butt, K. Gadsby, and C. Deighton
Rheumatology 2008; 47: 180-182.
[Abstract]
[Full Text]
- CLINICAL
Evaluating the adequacy of disease control in patients with rheumatoid arthritis: a RAND appropriateness panel
- D. E. Furst, R. J. Halbert, C. O. Bingham, III, S. Fukudome, L. Anderson, P. Bonafede, V. Bray, S. B. Cohen, Y. R. S. Sherrer, E. W. S. St Clair, J. R. P. Tesser, M. Weinblatt, and R. W. Dubois
Rheumatology 2008; 47: 194-199.
[Abstract]
[Full Text]
- CLINICAL
Evaluation of latent tuberculosis infection in patients with inflammatory arthropathies before treatment with TNF- blocking drugs using a novel flow-cytometric interferon- release assay
- R. Dinser, M. Fousse, U. Sester, K. Albrecht, M. Singh, H. Köhler, U. Müller-Ladner, and M. Sester
Rheumatology 2008; 47: 212-218.
[Abstract]
[Full Text]
- CLINICAL
Long-term exposure to medium-dose glucocorticoid therapy associates with hypertension in patients with rheumatoid arthritis
- V. F. Panoulas, K. M. J. Douglas, A. Stavropoulos-Kalinoglou, G. S. Metsios, P. Nightingale, M. D. Kita, M. S. Elisaf, and G. D. Kitas
Rheumatology 2008; 47: 72-75.
[Abstract]
[Full Text]
- CLINICAL
Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies
- M. Svenson, P. Geborek, T. Saxne, and K. Bendtzen
Rheumatology 2007; 46: 1828-1834.
[Abstract]
[Full Text]
- LETTERS TO THE EDITOR
Adherence to immunosuppressant drugs in patients with connective tissue diseases
- D. Pyne and K. Chaabo
Rheumatology 2007; 46: 1859-a.
[Extract]
[Full Text]
- CLINICAL
Heart failure among younger rheumatoid arthritis and Crohn's patients exposed to TNF- antagonists
- J. R. Curtis, J. M. Kramer, C. Martin, K. G. Saag, N. Patkar, D. Shatin, M. Burgess, A. Xie, and M. M. Braun
Rheumatology 2007; 46: 1688-1693.
[Abstract]
[Full Text]
- CLINICAL
The cost-effectiveness of etanercept and infliximab for the treatment of patients with psoriatic arthritis
- Y. Bravo Vergel, N. S. Hawkins, K. Claxton, C. Asseburg, S. Palmer, N. Woolacott, I. N. Bruce, and M. J. Sculpher
Rheumatology 2007; 46: 1729-1735.
[Abstract]
[Full Text]
- REVIEWS
The pharmacogenetics of methotrexate
- S. L. Hider, I. N. Bruce, and W. Thomson
Rheumatology 2007; 46: 1520-1524.
[Abstract]
[Full Text]
- LETTERS TO THE EDITOR
A patient's perspective on drug regulation
- P. Huston
Rheumatology 2007; 46: 1618-a.
[Extract]
[Full Text]
|
|
